Effects of topical application of metronidazole-containing mucoadhesive lipogel in periodontal pockets by Toskić-Radojičić Marija et al.
Број 7-8 ВОЈНОСАНИТЕТСКИ ПРЕГЛЕД Страна 565
Toskić-Radojičić M, et al. Vojnosanit Pregl 2005; 62(7-8): 565−568.
UDC: 615.283.612.1:616.314.17–008.1
Effects of topical application of metronidazole-
-containing mucoadhesive lipogel in
periodontal pockets
Marija Toskić-Radojičić*, Zorka Nonković
†, Irma Lončar
‡,
Milomir Varjačić
§
Military Medical Academy, *Institute of Pharmacy, 
†Institute of Preventive Medicine,
§Department of Stomatology, Belgrade; 
‡Vetprom hemikalije, Belgrade
Introduction. Metronidazole is the drug of choice in the treatment of periodontal pockets
up to 5 mm in depth. It is topically applied – directly into the periodontal pockets. There
are no registred trademark preparations for this purpose in the market of Serbia and
Montenegro. The aim of our latest research was to test the efficacy of newly formulated
preparation containing 25% metronidazole suspended in a lipogel in vitro – in anaerobic
cultures isolated from the periodontal pockets, and in vivo – by the direct application into
periodontal pockets. Methods. Preparation efficacy was tested in a randomized controlled
study involving 25 patients, and was confirmed by the membrane-free agar diffusion
method on the anaerobic strains isolated from the periodontal pockets. The duration of the
testing was 30 days. The preparation was applied twice – immediately after the taking of
the first swab, and on day 15, when the control swab was taken for the assessment of the
effects of the applicd preparation. Results. Seven anaerobic strains were isolated and
tested, and each was confirmed as highly susceptible to metronidazole. Anaerobic strains
were not isolated in any of the pockets treated with metronidazole-containing lipogel. The
strains isolated in the control pockets were the same as were those at the beginning of the
study. Conclusion. Metronidazole, in a lipogel-type base applied in the concentration of
25%, provided an efficient treatment of anaerobic infection in the periodontal pockets.
K e y   w o r d s : periodontal pocket; metronidazole; adhesives; gels.
Introduction
Much attention is paid presently to the conservative
treatment of periodontal disease. Firstly, the periodontal
pocket conservative treatment is practiced, and the best re-
sults are achieved if the periodontal pockets are not deeper
than 5 mm.
Beside the periodontal pocket debridement (subgingi-
val scaling and curettage), topical application of metronida-
zole seems to be very efficacious. Metronidazole efficiently
inhibited anaerobic microorganisms in the periodontal
pockets (1–5). The basic problem in manufacturing prepa-
rations applied to periodontal pockets is to obtain the ade-
quate mucoadhesivity, i.e., the maintenance of the drug at
the site of application (6–8).
Biomucoadhesive preparations can be formulated as
hydrogels or as lipogels. Lipogels can contain lipids and
emulsifiers of both types (producing oil-in-water and water-
in-oil type emulsions). In contact with mucus, they form an
amphiphilic preparation that is gradually washed down. In
our earlier research, metronidazole-containing hydrogel
preparations (9–11) were formulated and their efficacy was
tested in vitro (9–11). The aim of this study was to evaluate
the efficacy of the preparations with metronidazole formu-
lated in a lipogel basis – a precursor of an amphiphilic
preparation in inhibiting the anaerobic flora isolated from
periodontal pockets.
Methods
Formulating the preparation
The original formulation of organic lipogel, containing
25% metronidazole, was made (12). Metronidazole was com-
pounded into the base according to the principles of manu-
facturing the suspension-type ointments (13). Pure metronida-
zole base was used, with the particle size of 0.15 (14).Страна 566 ВОЈНОСАНИТЕТСКИ ПРЕГЛЕД Број 7-8
The medium consisted of a complex emulsifier, ses-
ame oil and an appropriate jellifying agent with the bioad-
hesive properties. As the complex emulsifier with the hy-
drophylic lipophilic balance 10.2 (15), a preparation with
amphiphilic properties was created ex tempore, at body
temperature and in contact with mucus. The advantage of
such formulations were their slow release characteristics,
since only the layer in contact with mucus gradually eluted.
The preparation had thixotropic rheological properties, ena-
bling the periodontal pockets to be well-filled, and the am-
phiphilic layer created to express good mucoadhesivity.
Preliminary testing of the preparation
In vitro testing was performed, using the membrane-
free diffusion method on blood agar with haemin and K vi-
tamin. A Peptococcus anaerobius strain, with the inoculum
density 10
6 ml
-1 was inoculated on a standard plate, stan-
dardized according to McFarland's standard No. 0.25.
Twenty-five milligrams of the preparation, which corre-
sponded to 6.25 mg of metronidazole, were measured (on
Mettler AT-100 scales) into a circular opening (4 mm in ra-
dius) in the plate. Following the 48-hour incubation, the
width of the obvious bacterial culture growth inhibition
zone was 56 mm, demonstrating the efficacy of preparation
and the release of metronidazole from the vehicle.
Experimental group
A total of 25 patients of both sexes, who had the diag-
nosis of periodontal disease, and were not treated within the
previous six months, were randomly chosen. In each patient
2 periodontal pockets were chosen, up to 5 mm in depth, of
which one was experimental and the other was the control.
The study was performed with the informed consent of the
patients.
Before the standard periodontal pocket treatment,
swabs were taken from both pockets by a culturette (anaer-
obe transport system). Next, the preparation described
above was applied into the experimental pocket, whereas
the control pocket was without treatment. Patients were
checked-up at days 15 and 30, by taking swabs from both
experimental and control periodontal pockets. Immediately
after taking the swab, on day 15 affter the first application
of the metronidasole containing gel, the preparation was re-
applied into the experimental pockets (10).
Results
The isolated strains are presented in Table 1. It shows
the number of positive cultures, and the maximal values of
the obvious bacterial culture growth inhibition zone width
(millimeters).
Table 1
In vitro efficacy of 25% metronidazol lipogel
against anaerobic cultures isolated
from periodontal pockets
Isolated strains
Inhibition zone
(mm)
Eubacterium spp.
Peptostreptococcus spp.
Bifidobacterium spp.
Bacteroides fragilis
Prevotella melaninogenica
Veillonella parvula
Peptococcus anaerobius
49 ± 1
48 ± 4
74 ± 2
54 ± 2
65 ± 3
44 ± 1
44 ± 2
Results for 25 studied patients are presented in Table 2
for days 0, 15 and 30, as representative for the swabs taken
from both experimental and control pockets in 4 patients.
Table 2. Anaerobic bacterial strains isolated from ex-
perimental treated by 25% metronidazole lipogel and con-
trol periodontal pockets without the treatment on days 0, 15
and 30
Discussion
All the swabs taken by culturette (both from the ex-
perimental and the control periodontal pockets) were proc-
essed by standard bacteriological procedures for isolating
anaerobic bacteria. A total of 7 strains were isolated. After
isolating and cultivating, every strain was reinoculated onto
plates by the above mentioned method, to test the efficacy
of the preparation in vivo, by measuring the width of the
obvious bacterial culture growth inhibition zone. We ap-
Table 2
Anaerobic bacterial strains isolated from experimental treated by 25% metronidazole
lipogel and control periodontal pockets without the treatment on days 0, 15 and 30
Day 0 Day 15 Day 30 Patient
No. Isolated anaerobic strain
ECECEC
Peptococcus anaerobius ++++–+ 1 Veillonella parvula ++–+–+
Bacteroides fragilis ++–+–+ 2 Eubacterium spp. ++++–+
Peptostrepto-coccus spp. +––––– 3 Prevotella melaninoge-nica ++++–+
Bifidobacte-rium spp. ++–+–+
4
Peptococcus anaerobius +–––––
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plied 25 mg of the preparation, containing 6.25 mg metro-
nidazole.
As it can be seen from the results of in vitro testing,
presented in Table 1, a total of 7 bacterial strains was iso-
lated (Eubacterium spp., Peptostreptococcus spp., Bifido-
bacterium spp., Bacteroides spp., Prevotella melanino-
genica, Veillonella parvula, Peptococcus anaerobius) from
both treated and untreated pokets. Each of the isolated
strains showed a high susceptibility to metronidazole with
the growth inhibition zone of 42–76 mm width. This was a
direct confirmation that 25 mg of the preparation (i.e., 6.25
mg metronidazole) was sufficient to inhibit the growth of
the strains referred to.
The results of in vivo testing, performed during 30
days in 25 patients, also confirmed the efficacy of the lipo-
gel preparations. The control pockets were with the same
bacteriological findings on days 0, 15, and 30, while in the
pokets treated by the tested formulation, the bacteriological
finding was negative on day 30 – no bacterial strains were
isolated (Table 2). In most cases, a negative bacteriological
finding in the pockets examined was already achieved on
day 15.
Conclusion
Our original formulation – metronidazole-containing
lipogel – was shown to be efficient in the eradication of
periodontal pocket's anaerobic strains  within the period of
30 days. In all of the patients, no anaerobic strains were
isolated from the treated pockets on day 30, whereas an-
aerobic cultures were always confirmed in the control, un-
treated pockets.
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Apstrakt
Toskić-Radojičić M, Nonković Z, Lončar I, Varjačić M. Vojnosanit Pregl 2005;
62(7-8): 565–568.
EFEKTI LOKALNE PRIMENE MUKOATHEZIVNOG LIPOGELA SA
METRONIDAZOLOM U PERIODONTALNE DŽEPOVE
Uvod. Metronidazol je lek izbora u lečenju periodontalnih džepova dubine do 5
mm. Primenjuje se lokalno – direktno u periodontalni džep. Na našem tržištu nemaСтрана 568 ВОЈНОСАНИТЕТСКИ ПРЕГЛЕД Број 7-8
registrovanih preparata ove namene. Formulisan je preparat koji sadrži 25%
metronidazola suspendovanog u lipogelu. Cilj je bio da se in vitro – na anaerobnim
kulturama izolovanim iz periodontalnih džepova i in vivo – direktnom aplikacijom u
periodontalne džepove, ispita efikasnost novoformulisanog preparata. Metode. U
randomizovanoj studiji efikasnost preparata je ispitivana na 25 bolesnika i pot-
vrđena je bezmembranskom difuzionom metodom u agaru na anaerobnim kul-
turama izolovanim iz periodontalnih džepova bolesnika uključenih u studiju. Testi-
ranje je trajalo 30 dana, a preparat je aplikovan dvokratno – neposredno posle
uzimanja prvog brisa i posle petnaest dana kada je uziman kontrolni bris za pro-
cenu efekta primenjenog preparata. Rezultati. Izolovano je 7 anaerobnih kultura i
za svaku je potvrđeno da je veoma osetljiva na metronidazol. Ni u jednom od
džepova tretiranih lipogelom sa metronidazolom 30 dana nisu izolovane anaerobne
kulture. U kontrolnim džepovima status je bio isti kao i na početku testiranja.
Zaključak. Metronidazol, primenjen u koncentraciji 25%, u podlozi tipa lipogela efi-
kasno sanira razvoj anaerobnih kultura u periodontalnim džepovima.
Kl juč ne reč i : periodontalni džep; metronidazol; adhezivi; geli.
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